Hologic HOLX operates across four segments, but investor attention last year remained particularly heightened on the Breast Health business. From expected gantry slowdowns impacting sales to improved ...
Marlborough-based Hologic, a medical technology firm specializing in women’s health, has entered into a partnership with international pharmaceutical firm Bayer to provide enhanced imaging mammogram ...
CEM is a highly sensitive and relatively low-cost breast imaging modality that combines digital mammography with the administration of a contrast agent to support breast cancer diagnosis and guide ...
MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX) will reveal new technologies reimagining the future of breast health at the 110 th Scientific Assembly and Annual Meeting of the ...
In a retrospective study conducted at Massachusetts General Hospital, researchers analyzed 5,000 digital breast tomosynthesis (3D mammography) screening exams performed between 2016 and 2019 using ...
New data on Hologic’s (Nasdaq: HOLX) breast cancer detection technologies will be presented at the Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA) in Chicago ...
Newport Hospital is acquiring three new state-of-the-art mammography units to provide patients the most sophisticated 3D tomosynthesis technology available for early detection of breast cancer. The ...
Hologic has put forward more data bolstering the use of its artificial intelligence programs for detecting breast cancer through mammography. The study, conducted at Massachusetts General Hospital and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results